Cuorips Inc.
Tokyo, JP· latest recorded location
CUORIPS INC. is named on 2 US grants and 4 published applications in this corpus. Its most frequent classification is A61P (Therapeutic uses of medicines).
- Granted patents
- 2
- Published applications
- 4
- Inventors
- 18
- Granted in 2026 so far
- 1
- Most recent grant
- 10 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2023 | 0 | 1 |
| 2024 | 0 | 2 |
| 2025 | 1 | 1 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 6 documents
Recent patents
- Disease-site-specific liposomal formulation10 Mar 2026US 12,569,437 B2
- Facility and implementation method for manufacturing of article using said facility28 Oct 2025US 12,455,083 B2
- Surgical method for delivering drug solution to myocardium20 Nov 2025US 2025/0352764 A1
- Pharmaceutical composition for improving cardiac function20 Jun 2024US 2024/0197753 A1
- Disease-site-specific liposomal formulation14 Mar 2024US 2024/0082154 A1
- Facility and implementation method for manufacturing of article using said facility2 Feb 2023US 2023/0032285 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.